{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:12:14Z","timestamp":1780881134627,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021j01409"],"award-info":[{"award-number":["2021j01409"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology","award":["2020y9155"],"award-info":[{"award-number":["2020y9155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-03021-4","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T18:02:50Z","timestamp":1670263370000},"page":"1114-1123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Claudin-6 enhances the malignant progression of gestational trophoblastic neoplasm by promoting proliferation and metastasis"],"prefix":"10.1007","volume":"25","author":[{"given":"Qibin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9559-7211","authenticated-orcid":false,"given":"Yifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"3","key":"3021_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ygyno.2018.04.001","volume":"149","author":"F Jiang","year":"2018","unstructured":"Jiang F, Wan XR, Xu T, Feng FZ, Ren T, Yang JJ, et al. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: a ten-year review of 1420 patients. Gynecologic Oncol. 2018;149(3):539\u201344. https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.001.","journal-title":"Gynecologic Oncol"},{"issue":"6","key":"3021_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1684\/abc.2013.0908","volume":"71","author":"AG Zohoun","year":"2013","unstructured":"Zohoun AG, Hounmenou K, Mechtani Sel I, Razine R, Dami A, Filali A, et al. Int\u00e9r\u00eat du dosage de l\u2019hormone chorionique gonadotrope dans les maladies trophoblastiques gestationnelles [Utility of hCG dosage in the management of gestational trophoblastic diseases]. Annales de Biologie Clinique. 2013;71(6):639\u201343. https:\/\/doi.org\/10.1684\/abc.2013.0908.","journal-title":"Annales de Biologie Clinique"},{"key":"3021_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.critrevonc.2017.04.001","volume":"114","author":"R Nadhan","year":"2017","unstructured":"Nadhan R, Vaman JV, Nirmala C, Sengodan SK, Hemalatha S, Rajan A, et al. Insights into dovetailing GTD and cancers. Critical Rev Oncol\/Hematol. 2017;114:77\u201390. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.04.001.","journal-title":"Critical Rev Oncol\/Hematol"},{"issue":"6","key":"3021_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/humupd\/dml029","volume":"12","author":"U Stenman","year":"2006","unstructured":"Stenman U, Tiitinen A, Alfthan H, Valmu LJ. The classification, functions and clinical use of different isoforms of HCG. HRU. 2006;12(6):769\u201384. https:\/\/doi.org\/10.1093\/humupd\/dml029.","journal-title":"HRU"},{"issue":"7","key":"3021_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.clinbiochem.2004.05.008","volume":"37","author":"U Stenman","year":"2004","unstructured":"Stenman U, Alfthan H, Hotakainen KJ. Human chorionic gonadotropin in cancer. CB. 2004;37(7):549\u201361. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.05.008.","journal-title":"CB"},{"issue":"3","key":"3021_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/CEJ.0b013e328337210e","volume":"19","author":"Q Wu","year":"2010","unstructured":"Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, et al. Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev. 2010;19(3):186\u201394. https:\/\/doi.org\/10.1097\/CEJ.0b013e328337210e.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"3021_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbamem.2007.10.018","volume":"1778","author":"G Krause","year":"2008","unstructured":"Krause G, Winkler L, Mueller S, Haseloff R, Piontek J, Blasig IJ, et al. Structure and function of claudins. BEBA. 2008;1778(3):631\u201345. https:\/\/doi.org\/10.1016\/j.bbamem.2007.10.018.","journal-title":"BEBA"},{"issue":"1","key":"3021_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-006-6314-1","volume":"64","author":"S Oliveira","year":"2007","unstructured":"Oliveira S, Morgado-D\u00edaz JJC. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. CMLS. 2007;64(1):17\u201328. https:\/\/doi.org\/10.1007\/s00018-006-6314-1.","journal-title":"CMLS"},{"issue":"1","key":"3021_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/PAS.0b013e31822cfa7e","volume":"36","author":"LM Sullivan","year":"2012","unstructured":"Sullivan LM, Yankovich T, Le P, Martinez D, Santi M, Biegel JA, et al. Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors. Am J Surg Pathol. 2012;36(1):73\u201380. https:\/\/doi.org\/10.1097\/PAS.0b013e31822cfa7e.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3021_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/j.1365-2559.2012.04314.x","volume":"61","author":"T Ushiku","year":"2012","unstructured":"Ushiku T, Shinozaki-Ushiku A, Maeda D, Morita S, Fukayama M. Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas. Histopathology. 2012;61(6):1043\u201356. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04314.x.","journal-title":"Histopathology"},{"issue":"2","key":"3021_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/dvdy.1174","volume":"222","author":"K Turksen","year":"2001","unstructured":"Turksen K, Troy T-C. Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn. 2001;222(2):292\u2013300. https:\/\/doi.org\/10.1002\/dvdy.1174.","journal-title":"Dev Dyn"},{"issue":"1","key":"3021_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5858\/arpa.2018-0234-RA","volume":"143","author":"P Hui","year":"2019","unstructured":"Hui P. Gestational trophoblastic tumors: a timely review of diagnostic pathology. Arch Pathol Lab Med. 2019;143(1):65\u201374. https:\/\/doi.org\/10.5858\/arpa.2018-0234-RA.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"3021_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4149\/neo_2020_190321N255","volume":"67","author":"A Vilotic","year":"2020","unstructured":"Vilotic A, Bojic-Trbojevic Z, Vicovac L, Jovanovic KM. Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells. Neoplasma. 2020;67(2):323\u201332. https:\/\/doi.org\/10.4149\/neo_2020_190321N255.","journal-title":"Neoplasma"},{"key":"3021_CR14","first-page":"293","volume":"57","author":"S Kingdon","year":"2012","unstructured":"Kingdon S, Coleman R, Ellis L, Hancock B. Deaths from gestational trophoblastic neoplasia: any lessons to be learned? JORM. 2012;57:293\u20136.","journal-title":"JORM"},{"issue":"2","key":"3021_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ygyno.2015.05.041","volume":"138","author":"N Neubauer","year":"2015","unstructured":"Neubauer N, Strohl A, Schink J, Lurain J. Fatal gestational trophoblastic neoplasia: an analysis of treatment failures at the brewer trophoblastic disease center from 1979\u20132012 compared to 1962\u20131978. GO. 2015;138(2):339\u201342. https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.041.","journal-title":"GO"},{"key":"3021_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","volume":"44","author":"PJ Ottevanger","year":"2017","unstructured":"Ottevanger PJ. Ovarian cancer stem cells more questions than answers. SICB. 2017;44:67\u201371. https:\/\/doi.org\/10.1016\/j.semcancer.2017.04.009.","journal-title":"SICB"},{"issue":"10","key":"3021_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. NM. 2017;23(10):1124\u201334. https:\/\/doi.org\/10.1038\/nm.4409.","journal-title":"NM"},{"key":"3021_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1242\/jcs.01004","volume":"117","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Ozawa MJ. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. JOCS. 2004;117:1675\u201385. https:\/\/doi.org\/10.1242\/jcs.01004.","journal-title":"JOCS"},{"issue":"2","key":"3021_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1242\/dmm.023184","volume":"9","author":"N Aiello","year":"2016","unstructured":"Aiello N, Stanger B. Echoes of the embryo: using the developmental biology toolkit to study cancer. JDM Mech. 2016;9(2):105\u201314. https:\/\/doi.org\/10.1242\/dmm.023184.","journal-title":"JDM Mech"},{"issue":"2","key":"3021_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/dvdy.21437","volume":"237","author":"WJ Anderson","year":"2008","unstructured":"Anderson WJ, Zhou Q, Alcalde V, Kaneko OF, Blank LJ, Sherwood RI, et al. Genetic targeting of the endoderm with claudin-6CreER. Dev Dyn. 2008;237(2):504\u201312. https:\/\/doi.org\/10.1002\/dvdy.21437.","journal-title":"Dev Dyn"},{"issue":"18","key":"3021_CR21","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.7150\/jca.55727","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Dang Q, Bo Y, Su X, Wang L, Sun J, et al. The expression of CLDN6 in hepatocellular carcinoma tissue and the effects of CLDN6 on biological phenotypes of hepatocellular carcinoma cells. J Cancer. 2021;12(18):5454\u201363. https:\/\/doi.org\/10.7150\/jca.55727.","journal-title":"J Cancer"},{"issue":"7","key":"3021_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/1541-7786.MCR-20-0835","volume":"19","author":"M Kojima","year":"2021","unstructured":"Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe T, et al. Aberrant Claudin-6-adhesion signaling promotes endometrial cancer progression via estrogen receptor \u03b1. Mol Cancer Res. 2021;19(7):1208\u201320. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0835.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"3021_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41419-019-2168-y","volume":"10","author":"S Yu","year":"2019","unstructured":"Yu S, Zhang Y, Li Q, Zhang Z, Zhao G, Xu J, et al. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 2019;10(12):949. https:\/\/doi.org\/10.1038\/s41419-019-2168-y.","journal-title":"Cell Death Dis"},{"key":"3021_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb6282","author":"FE Kong","year":"2021","unstructured":"Kong FE, Li GM, Tang YQ, Xi SY, Loong JHC, Li MM, et al. Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.abb6282.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3021_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13046-019-1359-9","volume":"38","author":"P Song","year":"2019","unstructured":"Song P, Li Y, Dong Y, Liang Y, Qu H, Qi D, et al. Estrogen receptor \u03b2 inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy. J Exp Clin Cancer Res. 2019;38(1):354. https:\/\/doi.org\/10.1186\/s13046-019-1359-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3021_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/cbf.3489","volume":"38","author":"L Huang","year":"2020","unstructured":"Huang L, Zhao C, Sun K, Yang D, Yan L, Luo D, et al. Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR\/AKT\/mTOR signalling pathway in hepatocellular carcinoma. Cell Biochem Function. 2020;38(5):541\u20138. https:\/\/doi.org\/10.1002\/cbf.3489.","journal-title":"Cell Biochem Function"}],"updated-by":[{"DOI":"10.1007\/s12094-024-03783-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000}}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-03021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-03021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-03021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:22:23Z","timestamp":1732706543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-03021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-03021-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12094-024-03783-z","asserted-by":"object"}]},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to grant number for Science and Technology Project of Health Commission of Fujian Province.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12094-024-03783-z","URL":"https:\/\/doi.org\/10.1007\/s12094-024-03783-z","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University (FMCH2021KRD020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}